St Helier, Jersey – IQ-AI Ltd, a medical services firm specializing in cancer treatment, announced on Wednesday that its wholly-owned subsidiary, Imaging Biometrics LLC, has submitted a request to the US Food & Drug Administration (FDA) for a Pediatric Rare Disease (PRD) designation for its gallium maltolate therapy. The request is aimed at facilitating the ... Read more